2007
DOI: 10.1016/j.pbb.2007.02.019
|View full text |Cite
|
Sign up to set email alerts
|

The dopamine D3 receptor antagonist NGB 2904 increases spontaneous and amphetamine-stimulated locomotion

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
28
1

Year Published

2007
2007
2012
2012

Publication Types

Select...
7
2

Relationship

2
7

Authors

Journals

citations
Cited by 43 publications
(34 citation statements)
references
References 60 publications
4
28
1
Order By: Relevance
“…The dose of NGB2904 pretreatment used is in accordance with previous studies in which NGB2904 enhanced cocaine-induced increases in NAc dopamine concentration and increased amphetaminestimulated locomotion [32,35,36] . In addition, we performed a dose-effect experiment by administering different dosages of NGB2904 (0.1, 0.5, 1, 3, and 5 mg/kg i.p.)…”
Section: Drug Treatmentsupporting
confidence: 60%
See 1 more Smart Citation
“…The dose of NGB2904 pretreatment used is in accordance with previous studies in which NGB2904 enhanced cocaine-induced increases in NAc dopamine concentration and increased amphetaminestimulated locomotion [32,35,36] . In addition, we performed a dose-effect experiment by administering different dosages of NGB2904 (0.1, 0.5, 1, 3, and 5 mg/kg i.p.)…”
Section: Drug Treatmentsupporting
confidence: 60%
“…A number of in vivo studies further support the selectivity of NGB2904 for D3 receptors [32,35,36] . To confirm the selectivity of NGB2904 in our experiments, we conducted a dose-response experiment by treating mice with different dosages of NGB2904 (0.1, 0.5, 1, 3, and 5 mg/kg, i.p.)…”
Section: Cocaine-induced Structural Remodeling Of Dendrites and Spinementioning
confidence: 87%
“…Preclinical data suggest that activation of the dopamine D 3 receptor with low doses of agonists, such as 7-OH-DPAT, quinelorane and PD 128,907, inhibits spontaneous motor activity (Daly & Waddington, 1993 ;Millan et al 2004), probably by activation of receptors in the NAc (Ouagazzal & Creese, 2000). By contrast, D 3 antagonists, such as nafadotride, U99194A, and NGB 2904, enhance locomotor activity (Clifford & Waddington, 1998 ;Pritchard et al 2007 ;Sautel et al 1995) in the rodent but are without effect in D 3 receptor knockout mice (Pritchard et al 2007). Although such findings were initially controversial due to the lack of selectivity of the original compounds used (Boulay et al 1999), more selective antagonists, like S33084, have confirmed that blockade of the D 3 receptor does not reduce spontaneous locomotor activity in an open field (Millan et al 2004), consistent with the current data : moreover, it produces a mild antiparkinsonian effect in the MPTP-lesioned marmoset without producing dyskinesia (Silverdale et al 2004).…”
Section: Discussionmentioning
confidence: 99%
“…Finally, we observed an increase, although not significant, in active and inactive lever pressing in rats administered with the lower dose of NGB 2904 (0.1 mg/kg), under FD condition. Although speculating on a non-significant effect is of questionable value, it is interesting to note that a stimulatory effect of low doses of NGB 2904 has been demonstrated on spontaneous and amphetamine-induced locomotor activity in mice (Pritchard et al, 2007).…”
Section: Discussionmentioning
confidence: 99%